ID   MPI_HUMAN               Reviewed;         423 AA.
AC   P34949; A8K8K9; Q96AB0;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   12-APR-2017, entry version 183.
DE   RecName: Full=Mannose-6-phosphate isomerase;
DE            EC=5.3.1.8;
DE   AltName: Full=Phosphohexomutase;
DE   AltName: Full=Phosphomannose isomerase;
DE            Short=PMI;
GN   Name=MPI; Synonyms=PMI1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Placenta, and Testis;
RX   PubMed=8307007; DOI=10.1111/j.1432-1033.1994.tb19954.x;
RA   Proudfoot A.E.I., Turcatti G., Wells T.N.C., Payton M.A., Smith D.J.;
RT   "Purification, cDNA cloning and heterologous expression of human
RT   phosphomannose isomerase.";
RL   Eur. J. Biochem. 219:415-423(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS CDG1B THR-51; ASN-131;
RP   GLN-152; SER-250 AND HIS-418.
RX   PubMed=10980531;
RX   DOI=10.1002/1098-1004(200009)16:3<247::AID-HUMU7>3.0.CO;2-A;
RA   Schollen E., Dorland L., de Koning T.J., Van Diggelen O.P.,
RA   Huijmans J.G.M., Marquardt T., Babovic-Vuksanovic D., Patterson M.,
RA   Imtiaz F., Winchester B., Adamowicz M., Pronicka E., Freeze H.,
RA   Matthijs G.;
RT   "Genomic organization of the human phosphomannose isomerase (MPI) gene
RT   and mutation analysis in patients with congenital disorders of
RT   glycosylation type Ib (CDG-Ib).";
RL   Hum. Mutat. 16:247-252(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Blood, and Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-102 AND SER-108, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   VARIANTS CDG1B LEU-102 AND THR-138.
RX   PubMed=9585601; DOI=10.1086/301873;
RA   Jaeken J., Matthijs G., Saudubray J.-M., Dionisi-Vici C., Bertini E.,
RA   de Lonlay P., Henri H., Carchon H., Schollen E., Van Schaftingen E.;
RT   "Phosphomannose isomerase deficiency: a carbohydrate-deficient
RT   glycoprotein syndrome with hepatic-intestinal presentation.";
RL   Am. J. Hum. Genet. 62:1535-1539(1998).
RN   [10]
RP   VARIANT CDG1B GLN-219.
RX   PubMed=9525984; DOI=10.1172/JCI2350;
RA   Niehues R., Hasilik M., Alton G., Koerner C., Schiebe-Sukumar M.,
RA   Koch H.G., Zimmer K.-P., Wu R., Harms E., Reiter K., von Figura K.,
RA   Freeze H.H., Harms H.K., Marquardt T.;
RT   "Carbohydrate-deficient glycoprotein syndrome type Ib: phosphomannose
RT   isomerase deficiency and mannose therapy.";
RL   J. Clin. Invest. 101:1414-1420(1998).
RN   [11]
RP   VARIANTS CDG1B CYS-255 AND THR-398.
RX   PubMed=11134235; DOI=10.1136/jmg.38.1.14;
RA   de Lonlay P., Seta N., Barrot S., Chabrol B., Drouin V., Gabriel B.M.,
RA   Journel H., Kretz M., Laurent J., Le Merrer M., Leroy A., Pedespan D.,
RA   Sarda P., Villeneuve N., Schmitz J., van Schaftingen E., Matthijs G.,
RA   Jaeken J., Koerner C., Munnich A., Saudubray J.-M., Cormier-Daire V.;
RT   "A broad spectrum of clinical presentations in congenital disorders of
RT   glycosylation I: a series of 26 cases.";
RL   J. Med. Genet. 38:14-19(2001).
RN   [12]
RP   VARIANTS CDG1B THR-140 AND GLN-219.
RX   PubMed=11350186; DOI=10.1006/mgme.2001.3161;
RA   Westphal V., Kjaergaard S., Davis J.A., Peterson S.M., Skovby F.,
RA   Freeze H.H.;
RT   "Genetic and metabolic analysis of the first adult with congenital
RT   disorder of glycosylation type Ib: long-term outcome and effects of
RT   mannose supplementation.";
RL   Mol. Genet. Metab. 73:77-85(2001).
RN   [13]
RP   VARIANT CDG1B CYS-129.
RX   PubMed=12357336; DOI=10.1038/sj.ejhg.5200858;
RA   Schollen E., Martens K., Geuzens E., Matthijs G.;
RT   "DHPLC analysis as a platform for molecular diagnosis of congenital
RT   disorders of glycosylation (CDG).";
RL   Eur. J. Hum. Genet. 10:643-648(2002).
RN   [14]
RP   VARIANT CDG1B HIS-295.
RX   PubMed=12414827; DOI=10.1136/jmg.39.11.849;
RA   Vuillaumier-Barrot S., Le Bizec C., de Lonlay P., Barnier A.,
RA   Mitchell G., Pelletier V., Prevost C., Saudubray J.-M., Durand G.,
RA   Seta N.;
RT   "Protein losing enteropathy-hepatic fibrosis syndrome in Saguenay-Lac
RT   St-Jean, Quebec is a congenital disorder of glycosylation type Ib.";
RL   J. Med. Genet. 39:849-851(2002).
CC   -!- FUNCTION: Involved in the synthesis of the GDP-mannose and
CC       dolichol-phosphate-mannose required for a number of critical
CC       mannosyl transfer reactions.
CC   -!- CATALYTIC ACTIVITY: D-mannose 6-phosphate = D-fructose 6-
CC       phosphate.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250};
CC   -!- PATHWAY: Nucleotide-sugar biosynthesis; GDP-alpha-D-mannose
CC       biosynthesis; alpha-D-mannose 1-phosphate from D-fructose 6-
CC       phosphate: step 1/2.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P34949-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P34949-2; Sequence=VSP_013357;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues, but more abundant in
CC       heart, brain and skeletal muscle.
CC   -!- DISEASE: Congenital disorder of glycosylation 1B (CDG1B)
CC       [MIM:602579]: A form of congenital disorder of glycosylation, a
CC       multisystem disorder caused by a defect in glycoprotein
CC       biosynthesis and characterized by under-glycosylated serum
CC       glycoproteins. Congenital disorders of glycosylation result in a
CC       wide variety of clinical features, such as defects in the nervous
CC       system development, psychomotor retardation, dysmorphic features,
CC       hypotonia, coagulation disorders, and immunodeficiency. The broad
CC       spectrum of features reflects the critical role of N-glycoproteins
CC       during embryonic development, differentiation, and maintenance of
CC       cell functions. CDG1B is clinically characterized by protein-
CC       losing enteropathy. {ECO:0000269|PubMed:10980531,
CC       ECO:0000269|PubMed:11134235, ECO:0000269|PubMed:11350186,
CC       ECO:0000269|PubMed:12357336, ECO:0000269|PubMed:12414827,
CC       ECO:0000269|PubMed:9525984, ECO:0000269|PubMed:9585601}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the mannose-6-phosphate isomerase type 1
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X76057; CAA53657.1; -; mRNA.
DR   EMBL; AF227218; AAF37697.1; -; Genomic_DNA.
DR   EMBL; AF227216; AAF37697.1; JOINED; Genomic_DNA.
DR   EMBL; AF227217; AAF37697.1; JOINED; Genomic_DNA.
DR   EMBL; AK292374; BAF85063.1; -; mRNA.
DR   EMBL; CH471136; EAW99296.1; -; Genomic_DNA.
DR   EMBL; BC017351; AAH17351.1; -; mRNA.
DR   EMBL; BC046357; AAH46357.1; -; mRNA.
DR   CCDS; CCDS10272.1; -. [P34949-1]
DR   CCDS; CCDS73757.1; -. [P34949-2]
DR   PIR; S41122; S41122.
DR   RefSeq; NP_001276085.1; NM_001289156.1.
DR   RefSeq; NP_001276086.1; NM_001289157.1. [P34949-2]
DR   RefSeq; NP_002426.1; NM_002435.2. [P34949-1]
DR   UniGene; Hs.75694; -.
DR   ProteinModelPortal; P34949; -.
DR   SMR; P34949; -.
DR   BioGrid; 110491; 20.
DR   IntAct; P34949; 1.
DR   STRING; 9606.ENSP00000318318; -.
DR   BindingDB; P34949; -.
DR   ChEMBL; CHEMBL2758; -.
DR   iPTMnet; P34949; -.
DR   PhosphoSitePlus; P34949; -.
DR   BioMuta; MPI; -.
DR   DMDM; 462567; -.
DR   OGP; P34949; -.
DR   EPD; P34949; -.
DR   MaxQB; P34949; -.
DR   PaxDb; P34949; -.
DR   PeptideAtlas; P34949; -.
DR   PRIDE; P34949; -.
DR   DNASU; 4351; -.
DR   Ensembl; ENST00000323744; ENSP00000318192; ENSG00000178802. [P34949-2]
DR   Ensembl; ENST00000352410; ENSP00000318318; ENSG00000178802. [P34949-1]
DR   GeneID; 4351; -.
DR   KEGG; hsa:4351; -.
DR   UCSC; uc002azc.3; human. [P34949-1]
DR   CTD; 4351; -.
DR   DisGeNET; 4351; -.
DR   GeneCards; MPI; -.
DR   GeneReviews; MPI; -.
DR   HGNC; HGNC:7216; MPI.
DR   HPA; HPA007200; -.
DR   MalaCards; MPI; -.
DR   MIM; 154550; gene.
DR   MIM; 602579; phenotype.
DR   neXtProt; NX_P34949; -.
DR   OpenTargets; ENSG00000178802; -.
DR   Orphanet; 79319; MPI-CDG.
DR   PharmGKB; PA30922; -.
DR   eggNOG; KOG2757; Eukaryota.
DR   eggNOG; COG1482; LUCA.
DR   GeneTree; ENSGT00390000016075; -.
DR   HOGENOM; HOG000241277; -.
DR   HOVERGEN; HBG000367; -.
DR   InParanoid; P34949; -.
DR   KO; K01809; -.
DR   OMA; QGEPWDT; -.
DR   OrthoDB; EOG091G078D; -.
DR   PhylomeDB; P34949; -.
DR   TreeFam; TF312831; -.
DR   Reactome; R-HSA-446205; Synthesis of GDP-mannose.
DR   UniPathway; UPA00126; UER00423.
DR   GenomeRNAi; 4351; -.
DR   PRO; PR:P34949; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000178802; -.
DR   CleanEx; HS_MPI; -.
DR   ExpressionAtlas; P34949; baseline and differential.
DR   Genevisible; P34949; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0004476; F:mannose-6-phosphate isomerase activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0000032; P:cell wall mannoprotein biosynthetic process; IBA:GO_Central.
DR   GO; GO:0009298; P:GDP-mannose biosynthetic process; IBA:GO_Central.
DR   GO; GO:0061611; P:mannose to fructose-6-phosphate metabolic process; IEA:Ensembl.
DR   GO; GO:0006486; P:protein glycosylation; IBA:GO_Central.
DR   Gene3D; 2.60.120.10; -; 2.
DR   InterPro; IPR001250; Man6P_Isoase-1.
DR   InterPro; IPR016305; Mannose-6-P_Isomerase.
DR   InterPro; IPR018050; Pmannose_isomerase-type1_CS.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   InterPro; IPR011051; RmlC_Cupin.
DR   PANTHER; PTHR10309; PTHR10309; 1.
DR   Pfam; PF01238; PMI_typeI; 1.
DR   PIRSF; PIRSF001480; Mannose-6-phosphate_isomerase; 1.
DR   PRINTS; PR00714; MAN6PISMRASE.
DR   SUPFAM; SSF51182; SSF51182; 1.
DR   TIGRFAMs; TIGR00218; manA; 1.
DR   PROSITE; PS00965; PMI_I_1; 1.
DR   PROSITE; PS00966; PMI_I_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome;
KW   Congenital disorder of glycosylation; Cytoplasm;
KW   Direct protein sequencing; Disease mutation; Isomerase; Metal-binding;
KW   Phosphoprotein; Reference proteome; Zinc.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    423       Mannose-6-phosphate isomerase.
FT                                /FTId=PRO_0000194235.
FT   ACT_SITE    295    295       {ECO:0000250}.
FT   METAL       110    110       Zinc. {ECO:0000250}.
FT   METAL       112    112       Zinc. {ECO:0000250}.
FT   METAL       137    137       Zinc. {ECO:0000250}.
FT   METAL       276    276       Zinc. {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES     102    102       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     108    108       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ     163    224       KVPEFQFLIGDEAATHLKQTMSHDSQAVASSLQSCFSHLMK
FT                                SEKKVVVEQLNLLVKRISQQA -> T (in isoform
FT                                2). {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_013357.
FT   VARIANT      51     51       M -> T (in CDG1B; dbSNP:rs764835081).
FT                                {ECO:0000269|PubMed:10980531}.
FT                                /FTId=VAR_022516.
FT   VARIANT     102    102       S -> L (in CDG1B; dbSNP:rs104894494).
FT                                {ECO:0000269|PubMed:9585601}.
FT                                /FTId=VAR_012338.
FT   VARIANT     129    129       Y -> C (in CDG1B).
FT                                {ECO:0000269|PubMed:12357336}.
FT                                /FTId=VAR_022517.
FT   VARIANT     131    131       D -> N (in CDG1B; dbSNP:rs566620411).
FT                                {ECO:0000269|PubMed:10980531}.
FT                                /FTId=VAR_022518.
FT   VARIANT     138    138       M -> T (in CDG1B; dbSNP:rs104894495).
FT                                {ECO:0000269|PubMed:9585601}.
FT                                /FTId=VAR_012339.
FT   VARIANT     140    140       I -> T (in CDG1B; dbSNP:rs773678732).
FT                                {ECO:0000269|PubMed:11350186}.
FT                                /FTId=VAR_012345.
FT   VARIANT     152    152       R -> Q (in CDG1B; dbSNP:rs766458792).
FT                                {ECO:0000269|PubMed:10980531}.
FT                                /FTId=VAR_022519.
FT   VARIANT     219    219       R -> Q (in CDG1B; dbSNP:rs104894489).
FT                                {ECO:0000269|PubMed:11350186,
FT                                ECO:0000269|PubMed:9525984}.
FT                                /FTId=VAR_012340.
FT   VARIANT     250    250       G -> S (in CDG1B; dbSNP:rs748090636).
FT                                {ECO:0000269|PubMed:10980531}.
FT                                /FTId=VAR_022520.
FT   VARIANT     255    255       Y -> C (in CDG1B).
FT                                {ECO:0000269|PubMed:11134235}.
FT                                /FTId=VAR_022521.
FT   VARIANT     295    295       R -> H (in CDG1B; dbSNP:rs28928906).
FT                                {ECO:0000269|PubMed:12414827}.
FT                                /FTId=VAR_022522.
FT   VARIANT     398    398       I -> T (in CDG1B; dbSNP:rs369326210).
FT                                {ECO:0000269|PubMed:11134235}.
FT                                /FTId=VAR_022523.
FT   VARIANT     418    418       R -> H (in CDG1B; dbSNP:rs863225087).
FT                                {ECO:0000269|PubMed:10980531}.
FT                                /FTId=VAR_022524.
SQ   SEQUENCE   423 AA;  46656 MW;  1612DD966B86D3AC CRC64;
     MAAPRVFPLS CAVQQYAWGK MGSNSEVARL LASSDPLAQI AEDKPYAELW MGTHPRGDAK
     ILDNRISQKT LSQWIAENQD SLGSKVKDTF NGNLPFLFKV LSVETPLSIQ AHPNKELAEK
     LHLQAPQHYP DANHKPEMAI ALTPFQGLCG FRPVEEIVTF LKKVPEFQFL IGDEAATHLK
     QTMSHDSQAV ASSLQSCFSH LMKSEKKVVV EQLNLLVKRI SQQAAAGNNM EDIFGELLLQ
     LHQQYPGDIG CFAIYFLNLL TLKPGEAMFL EANVPHAYLK GDCVECMACS DNTVRAGLTP
     KFIDVPTLCE MLSYTPSSSK DRLFLPTRSQ EDPYLSIYDP PVPDFTIMKT EVPGSVTEYK
     VLALDSASIL LMVQGTVIAS TPTTQTPIPL QRGGVLFIGA NESVSLKLTE PKDLLIFRAC
     CLL
//
